Evidence map›Paper›PMID 23185441›Full record

ArticlePloS one2012

HIV-1 clade D is associated with increased rates of CD4 decline in a Kenyan cohort.

Lyle R McKinnon, Nico J Nagelkerke, Rupert Kaul, Souradet Y Shaw, Rupert Capina, Ma Luo, Anthony Kariri, Winnie Apidi, Makobu Kimani, Charles Wachihi and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Lyle R McKinnonDepartment of Medicine, University of Toronto, Toronto, Canada. sijuisijali@gmail.com
Nico J Nagelkerke
Rupert Kaul
Souradet Y Shaw
Rupert Capina
Ma Luo
Anthony Kariri
Winnie Apidi
Makobu Kimani
Charles Wachihi
Walter Jaoko
A Omu Anzala
Joshua Kimani
T Blake Ball
Francis A Plummer
University of Manitoba · CAUniversity of Nairobi · KEPublic Health Agency of Canada · CAKenya AIDS Vaccine Initiative · KEUniversity of Toronto · CA

Funding

Immunogenetic /Immunoregulatory Basis for HIV-1 ResponseR01AI056980 · NIAID · UNIVERSITY OF MANITOBA · PI PLUMMER, FRANCIS A · 2004 to 2008
$1.8M
CIHR HOP-43135NIAID NIH HHS R01 AI056980NIAID NIH HHS R01 AI56980 A1
6 · The paper itself

Abstract

HIV-1 is grouped phylogenetically into clades, which may impact rates of HIV-1 disease progression. Clade D infection in particular has been shown to be more pathogenic. Here we confirm in a Nairobi-based prospective female sex worker cohort (1985-2004) that Clade D (n = 54) is associated with a more rapid CD4 decline than clade A1 (n = 150, 20.6% vs 13.4% decline per year, 1.53-fold increase, p = 0.015). This was independent of "protective" HLA and country of origin (p = 0.053), which in turn were also independent predictors of the rate of CD4 decline (p = 0.026 and 0.005, respectively). These data confirm that clade D is more pathogenic than clade A1. The precise reason for this difference is currently unclear, and requires further study. This is first study to demonstrate difference in HIV-1 disease progression between clades while controlling for protective HLA alleles.

Indexed as

CD4 AntigensHIV-1HIV InfectionsSex WorkersAdultAllelesBlack PeopleDisease ProgressionEvolution, MolecularFemaleHLA AntigensHumansKenyaPhylogenyCD4 AntigensHLA Antigens

Identifiers

PMID23185441
PMCPMC3504142
OpenAlexW2146843749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.